Copernicus Capital Management, LLC - Q2 2021 holdings

$6.34 Million is the total value of Copernicus Capital Management, LLC's 11 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
ORTX ExitORCHARD THERAPEUTICS PLCads$0-15,000
-100.0%
-1.76%
TDOC ExitTELADOC HEALTH INC$0-1,500
-100.0%
-4.41%
BCEL ExitATRECA INC$0-18,000
-100.0%
-4.46%
ARDX ExitARDELYX INC$0-50,000
-100.0%
-5.35%
TGTX ExitTG THERAPEUTICS INC$0-7,000
-100.0%
-5.44%
RCKT ExitROCKET PHARMACEUTICALS INC$0-8,000
-100.0%
-5.74%
RVMD ExitREVOLUTION MEDICINES INC$0-10,000
-100.0%
-7.42%
ABBV ExitABBVIE INC$0-6,000
-100.0%
-10.49%
REGN ExitREGENERON PHARMACEUTICALS$0-1,500
-100.0%
-11.47%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-10,000
-100.0%
-12.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC15Q2 202128.6%
THERMO FISHER SCIENTIFIC INC10Q3 202113.8%
ZOETIS INC10Q1 202013.0%
FATE THERAPEUTICS INC9Q3 202113.7%
ILLUMINA INC9Q4 201911.8%
BIOMARIN PHARMACEUTICAL INC8Q3 202114.7%
BRISTOL-MYERS SQUIBB CO8Q4 202012.2%
INTUITIVE SURGICAL INC7Q2 201911.8%
STRYKER CORP7Q2 201911.6%
IQVIA HLDGS INC7Q4 20208.2%

View Copernicus Capital Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-14
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14

View Copernicus Capital Management, LLC's complete filings history.

Compare quarters

Export Copernicus Capital Management, LLC's holdings